Otsuka Medical Devices was established for the purpose of strategically unifying the Otsuka Group’s operations in the field of medical devices. Through our work with medical devices, we hope to contribute to progress in the treatment of patients with drug-refractory and intractable diseases and offer new options in healthcare.
We mourn the loss of those who have died from COVID-19, extend our sympathies to their loved ones, wish COVID-19 survivors rapid and permanent recoveries, and express our gratitude to medical professionals and others who support the ill.

Press Releases

Archives

2020.12.10

Otsuka Announces Results of Two International Clinical Studies in Patients with Treatment Resistant Hypertension and Breakthrough Device Designation for ParadiseTM Ultrasound Renal Denervation System for Uncontrolled Hypertension　

2018.12.13

Otsuka Medical Devices and Veryan Medical Announce Completion of Acquisition　

2018.07.10

Otsuka Medical Devices, Otsuka Holdings and ReCor Medical Announce Signing of Merger Agreement　

2018.04.27

Otsuka Pharmaceutical Factory acquires all the shares of Lilium Otsuka held by Otsuka Medical Devices, making it a whollyowned subsidiary　

2018.01.19

Otsuka Signs Statement of Support for Women’s Empowerment Principles　

News

Archives

2020.12.16

Otsuka Group Initiatives Related to COVID-19　

2020.01.09

Beware of Scam Communications via Social Media Claiming to Represent Otsuka Medical Devices　

2018.07.12

Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan　

2012.09.28

Insurance coverage granted to JIMRO Co., Ltd.'s Adacolumn for use in intractable dermatological illnesses

About Otsuka Medical Devices Corporate Information Otsuka Group's CSR
Back to top
OTSUKA
Copyright (C) Otsuka Medical Devices Co., Ltd.